Shortening of primary cilia length is associated with urine concentration in the kidneys.
Aquaporin 2
Histone deacetylase 6
Osmolality
Primary cilia
Water deprivation
Journal
Kidney research and clinical practice
ISSN: 2211-9132
Titre abrégé: Kidney Res Clin Pract
Pays: Korea (South)
ID NLM: 101586778
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
29
11
2022
accepted:
25
02
2023
medline:
14
6
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
ppublish
Résumé
The primary cilium, a microtubule-based cellular organelle present in certain kidney cells, functions as a mechano-sensor to monitor fluid flow in addition to various other biological functions. In kidneys, the primary cilia protrude into the tubular lumen and are directly exposed to pro-urine flow and components. However, their effects on urine concentration remain to be defined. Here, we investigated the association between primary cilia and urine concentration. Mice either had free access to water (normal water intake, NWI) or were not allowed access to water (water deprivation, WD). Some mice received tubastatin, an inhibitor of histone deacetylase 6 (HDAC6), which regulates the acetylation of α-tubulin, a core protein of microtubules. WD decreased urine output and increased urine osmolality, concomitant with apical plasma membrane localization of aquaporin 2 (AQP2) in the kidney. After WD, compared with after NWI, the lengths of primary cilia in renal tubular epithelial cells were shortened and HDAC6 activity increased. WD induced deacetylation of α-tubulin without altering α-tubulin levels in the kidney. Tubastatin prevented the shortening of cilia through increasing HDAC6 activity and consequently increasing acetylated α-tubulin expression. Furthermore, tubastatin prevented the WD-induced reduction of urine output, urine osmolality increase, and apical plasma membrane localization of AQP2. WD shortens primary cilia length through HDAC6 activation and α-tubulin deacetylation, while HDAC6 inhibition blocks the WD-induced changes in cilia length and urine output. This suggests that cilia length alterations are involved, at least in part, in the regulation of body water balance and urine concentration.
Sections du résumé
BACKGROUND
BACKGROUND
The primary cilium, a microtubule-based cellular organelle present in certain kidney cells, functions as a mechano-sensor to monitor fluid flow in addition to various other biological functions. In kidneys, the primary cilia protrude into the tubular lumen and are directly exposed to pro-urine flow and components. However, their effects on urine concentration remain to be defined. Here, we investigated the association between primary cilia and urine concentration.
METHODS
METHODS
Mice either had free access to water (normal water intake, NWI) or were not allowed access to water (water deprivation, WD). Some mice received tubastatin, an inhibitor of histone deacetylase 6 (HDAC6), which regulates the acetylation of α-tubulin, a core protein of microtubules.
RESULTS
RESULTS
WD decreased urine output and increased urine osmolality, concomitant with apical plasma membrane localization of aquaporin 2 (AQP2) in the kidney. After WD, compared with after NWI, the lengths of primary cilia in renal tubular epithelial cells were shortened and HDAC6 activity increased. WD induced deacetylation of α-tubulin without altering α-tubulin levels in the kidney. Tubastatin prevented the shortening of cilia through increasing HDAC6 activity and consequently increasing acetylated α-tubulin expression. Furthermore, tubastatin prevented the WD-induced reduction of urine output, urine osmolality increase, and apical plasma membrane localization of AQP2.
CONCLUSIONS
CONCLUSIONS
WD shortens primary cilia length through HDAC6 activation and α-tubulin deacetylation, while HDAC6 inhibition blocks the WD-induced changes in cilia length and urine output. This suggests that cilia length alterations are involved, at least in part, in the regulation of body water balance and urine concentration.
Identifiants
pubmed: 37313611
pii: j.krcp.22.274
doi: 10.23876/j.krcp.22.274
pmc: PMC10265211
doi:
Types de publication
Journal Article
Langues
eng
Pagination
312-324Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2020R1A2C2006903
Références
Am J Physiol Renal Physiol. 2013 May 15;304(10):F1283-94
pubmed: 23515720
Nephron. 1998 Dec;80(4):458-67
pubmed: 9832646
Vascul Pharmacol. 2015 Sep;72:130-40
pubmed: 25921924
J Cell Sci. 2010 Feb 15;123(Pt 4):511-8
pubmed: 20144999
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F791-F805
pubmed: 28122715
Anat Rec. 1975 Jul;182(3):339-43
pubmed: 1155803
Chonnam Med J. 2018 May;54(2):83-89
pubmed: 29854673
Nihon Rinsho. 1980 Aug;38(8):2860-70
pubmed: 7009917
Acta Pharmacol Sin. 2012 Feb;33(2):230-6
pubmed: 22212389
Cell Rep. 2018 Aug 14;24(7):1930
pubmed: 30110647
EMBO J. 2002 Dec 16;21(24):6820-31
pubmed: 12486003
Nat Commun. 2014 Nov 06;5:5308
pubmed: 25374274
Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1398-F1405
pubmed: 30089029
Am J Physiol Cell Physiol. 2007 Sep;293(3):C1129-38
pubmed: 17626240
Cell Cycle. 2011 Aug 15;10(16):2683-90
pubmed: 21814045
Curr Biol. 2007 Sep 18;17(18):1586-94
pubmed: 17825558
Annu Rev Physiol. 2005;67:515-29
pubmed: 15709968
Am J Physiol Lung Cell Mol Physiol. 2013 Sep 15;305(6):L419-31
pubmed: 23873844
Sci Rep. 2016 Feb 29;6:22281
pubmed: 26923764
Sci Rep. 2016 Jun 08;6:27775
pubmed: 27270990
J Anat. 2008 Aug;213(2):79-85
pubmed: 18537851
Acta Physiol Lat Am. 1975;25(2):83-8
pubmed: 5846
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94
pubmed: 12677000
Curr Opin Nephrol Hypertens. 2003 Sep;12(5):517-20
pubmed: 12920399
J Am Soc Nephrol. 2009 Oct;20(10):2147-53
pubmed: 19608704
Redox Biol. 2019 Jan;20:38-45
pubmed: 30292083
Results Probl Cell Differ. 2017;60:281-321
pubmed: 28409350
J Biol Chem. 2001 Apr 13;276(15):11870-6
pubmed: 11150293
Sci Rep. 2015 Aug 06;5:12917
pubmed: 26246421
J Am Assoc Lab Anim Sci. 2013;52(3):233-9
pubmed: 23849404
Am J Physiol Cell Physiol. 2015 Feb 1;308(3):C198-208
pubmed: 25428884
Int J Vasc Med. 2011;2011:376281
pubmed: 21748021
Endocr Connect. 2015 Jun;4(2):86-91
pubmed: 25712898
Mol Med. 2018 Jun 26;24(1):33
pubmed: 30134806
J Membr Biol. 2003 Jan 1;191(1):69-76
pubmed: 12532278
Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1817-1828
pubmed: 28495528
EMBO J. 2003 Mar 3;22(5):1168-79
pubmed: 12606581
Nature. 2002 May 23;417(6887):455-8
pubmed: 12024216
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F706-F720
pubmed: 28637787
Cell Death Dis. 2018 Apr 25;9(5):488
pubmed: 29695796